Immunosuppression is essential to ensure recipient and graft survivals after liver
transplantation (LT). However, our understanding and management of the immune system …

Cytokine adsorption can resolve different complications characteristic of transplantation
medicine, such as cytokine storm activation and blood ABO and immune incompatibilities …

Immunoadsorption is well known to selectively remove immunoglobulins and immune
complexes from plasma and is applied in a variety of autoimmune diseases and for …

Nearly 18% of patients on a waiting list for kidney transplantation (KT) are highly sensitized,
which make access to KT more difficult. We assessed the efficacy and tolerance of different …

One of the principal obstacles in transplantation from living donors is that approximately
30% are immunologically incompatible because of the presence in the recipient of …

Simple Summary The most common cause of late allograft failure is chronic active antibody-
mediated rejection (ABMR), but no effective therapy is available. Different …

Therapeutic apheresis (TA) plays a significant role in various aspects of renal
transplantation. It has been a necessary preconditioning component in ABO incompatible …

Introduction The use of therapeutic apheresis (TA) either as stand‐alone or adjunctive
treatment in kidney transplantation has increased over the years to become a leading …

Therapeutic plasma exchange (TPE) is a well-established therapeutic procedure commonly
used in many disorders of autoimmune etiology. The beneficial effects of TPE occur through …

Introduction: Immunoadsorption (IA) of isohemagglutinins is an often-crucial procedure in
preparation of major ABO blood group-incompatible living donor kidney transplantation …